Shilpa Medicare Limited, Unit 4, Jadcherla, Telangana, India was inspected by AGES, Austria from 27 July, 2026 until 30 July, 2026.

European GMP certification validates compliance standards at the Jadcherla finished dosage facility.

Following a successful inspection, the Unit has been issued GMP Certification from AGES, Austria.

This Unit of Shilpa Medicare is engaged in the manufacturing, testing and distribution of sterile Injections and non-sterile tablets and Capsule finished dosage forms in Europe and rest of the world markets.